Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

August 20, 2026

Study Completion Date

August 20, 2027

Conditions

Solid Tumor

Interventions

BIOLOGICAL

Anti ALPP CAR-T cells treatment

anti ALPP CAR-T cells Treatment follows a lymphodepletion Drug: Fludarabine and Cyclophosphamide.

Trial Locations (1)

RECRUITING

The Jinling Hospital, Nanjing

All Listed Sponsors

collaborator

The Jinling Hospital

UNKNOWN

lead

TCRCure Biopharma Ltd.

INDUSTRY